When it comes to questions about the need for laser in diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR), the answers are “yes” and “no,” depending on the clinical scenario.
Anti-vascular endothelial growth factor (VEGF) therapy is a viable alternative to panretinal photocoagulation (PRP) in eyes with proliferative diabetic retinopathy (PDR).
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
